NO912823L - PROCEDURE FOR THE PREPARATION OF THE CLASS II PROTEIN OF NEISSERIA MENINGITIDIS AND VACCINES CONTAINING THIS. - Google Patents

PROCEDURE FOR THE PREPARATION OF THE CLASS II PROTEIN OF NEISSERIA MENINGITIDIS AND VACCINES CONTAINING THIS.

Info

Publication number
NO912823L
NO912823L NO91912823A NO912823A NO912823L NO 912823 L NO912823 L NO 912823L NO 91912823 A NO91912823 A NO 91912823A NO 912823 A NO912823 A NO 912823A NO 912823 L NO912823 L NO 912823L
Authority
NO
Norway
Prior art keywords
protein
class
procedure
preparation
neisseria meningitidis
Prior art date
Application number
NO91912823A
Other languages
Norwegian (no)
Other versions
NO912823D0 (en
Inventor
Allen I Oliff
Margaret A Liu
Arthur Friedman
Joseph Y Tai
John J Donnelly
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO912823D0 publication Critical patent/NO912823D0/en
Publication of NO912823L publication Critical patent/NO912823L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55516Proteins; Peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
NO91912823A 1990-07-19 1991-07-18 PROCEDURE FOR THE PREPARATION OF THE CLASS II PROTEIN OF NEISSERIA MENINGITIDIS AND VACCINES CONTAINING THIS. NO912823L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55532990A 1990-07-19 1990-07-19
US71527491A 1991-06-19 1991-06-19

Publications (2)

Publication Number Publication Date
NO912823D0 NO912823D0 (en) 1991-07-18
NO912823L true NO912823L (en) 1992-01-20

Family

ID=27070858

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912823A NO912823L (en) 1990-07-19 1991-07-18 PROCEDURE FOR THE PREPARATION OF THE CLASS II PROTEIN OF NEISSERIA MENINGITIDIS AND VACCINES CONTAINING THIS.

Country Status (10)

Country Link
JP (1) JPH0655679B2 (en)
KR (1) KR920002632A (en)
AU (1) AU8113691A (en)
CA (1) CA2050635A1 (en)
FI (1) FI913475A (en)
IL (1) IL98839A0 (en)
MX (1) MX9100275A (en)
NO (1) NO912823L (en)
NZ (1) NZ238974A (en)
PT (1) PT98382A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60042114D1 (en) * 1999-04-30 2009-06-10 Craig J Venter Inst Inc GENERIC SEQUENCES OF NEISSERIA AND METHOD FOR THEIR USE
US7198707B2 (en) * 2002-12-13 2007-04-03 Korea Power Engineering Co. Inc. Apparatus for cathodic protection in an environment in which thin film corrosive fluids are formed and method thereof
KR100485953B1 (en) * 2002-12-13 2005-05-06 한국전력기술 주식회사 Method for cathodic protection for metal structure

Also Published As

Publication number Publication date
JPH0616569A (en) 1994-01-25
NZ238974A (en) 1992-12-23
NO912823D0 (en) 1991-07-18
PT98382A (en) 1992-05-29
CA2050635A1 (en) 1992-01-20
KR920002632A (en) 1992-02-28
IL98839A0 (en) 1992-07-15
AU8113691A (en) 1992-01-23
MX9100275A (en) 1992-02-28
FI913475A (en) 1992-01-20
JPH0655679B2 (en) 1994-07-27
FI913475A0 (en) 1991-07-18

Similar Documents

Publication Publication Date Title
WO1990006696A3 (en) Meningococcal class 1 outer-membrane protein vaccine
DK163991C (en) DICHLORANILIN DERIVATIVES, PROCEDURE FOR PREPARING THESE, AND PHARMACEUTICAL PREPARATIONS CONTAINING THE DERIVATIVES
DK343388A (en) 2,2-DIMETHYLCHROMAN-3-OL DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF, PHARMACEUTICAL AGENTS CONTAINING THE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF PHARMACEUTICAL AGENTS
NO895012L (en) PROCEDURE FOR THE PREPARATION OF Permanent titanium dioxide pigments.
NO914242D0 (en) CHEESE GUM, AND PROCEDURE FOR THE PREPARATION OF SUCH
NO890062D0 (en) 3,5-DIHYDROCARBOXYLIC ACIDS AND DERIVATIVES THEREOF, AND PROCEDURES FOR THE PREPARATION OF THESE.
DK642588A (en) INDANDER DERIVATIVES, PROCEDURE FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
DK567188A (en) 2,2-DIMETHYL CHROMINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THE DERIVATIVES
DK135988A (en) 2,5-DIHYDROPYROLES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES
NO892269L (en) NON-HYPERGYLYCOSYLED HEPATITY B VIRUS PROTEINS AND EXPRESSION "CASSETTE" AND PROCEDURE FOR THE PREPARATION OF THE PROTEINS.
DK469189A (en) SUBSTITUTED THIENOPYRANES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
NO893794L (en) PROCEDURE FOR THE PREPARATION OF IMPROVED HYDROLYZEATED PROTEIN.
NO912823L (en) PROCEDURE FOR THE PREPARATION OF THE CLASS II PROTEIN OF NEISSERIA MENINGITIDIS AND VACCINES CONTAINING THIS.
DK401988A (en) 11-SUBSTITUTED 5-ARYL-5H, 11H-PYRROLO (2,1-C) - (1,4) BENZOXAZEPINES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
DK131188D0 (en) 3- (2-HALOGENALKYL) -1,4-OXATHIINES AND 2 (2-HALOGENALKYL) -1,4-DITHIINES, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE FOR THE TREATMENT OF LEUKAEMI AND TUMORS
DE68918189T2 (en) Neisseria vaccine.
NO891926L (en) PROCEDURE FOR THE PREPARATION OF STABLE PROTEIN OR PEPTIDE PREPARATIONS.
DK146389D0 (en) (1,3-DIOXOLAN-4-YLMETHYLTHIO) PHENYL) CARBAMATES, PROCEDURES FOR PREPARING THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
NO912822D0 (en) PROCEDURE FOR THE PREPARATION OF THE CLASS II PROTEIN FRUIT MEMBRANE FOR NEISSERIA MENINGITIDIS.
DK165789C (en) 4-OXO-4H-PYRIMIDOOE2,1, AAAISOQUINOLINE DERIVATIVES, ANALOGUE PROCEDURES FOR PREPARING THEREOF, PHARMACEUTICAL PREPARATION CONTAINING THESE, AND THE DERIVATIVES FOR USE AS ANTI-ANALYSIS
AU2715288A (en) Human respiratory syncytialvirus vaccine derived from the 1a (9.5 kd) protein
DK39388A (en) ISOXAZOLE DERIVATIVES, PROCEDURES FOR PREPARING IT, AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH DERIVATIVES
NO912824L (en) PROCEDURE FOR THE PREPARATION OF THE CLASS II PROTEIN FRUIT MEMBRANE FOR NEISSERIA MENINGITIDIS.
NO893795L (en) PROCEDURE FOR THE PREPARATION OF IMPROVED HYDROLYZEATED PROTEIN.
DK179489D0 (en) OXAZOLOPYRIDE INGREDIENTS, PROCEDURES FOR PREPARING IT, AND PHARMACEUTICAL AGENTS CONTAINING THESE